Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Peter L Turecek"'
Sensitive and specific assessment of recombinant von Willebrand factor in platelet function analyzer
Autor:
Isabell Pekrul, Thorsten Kragh, Peter L Turecek, Aaron R Novack, Helmut W Ott, Michael Spannagl
Publikováno v:
Platelets, Vol 30, Iss 2, Pp 264-270 (2019)
Background: Recombinant von Willebrand factor (rVWF), which was licensed in the United States in 2015, has the multimeric distribution of freshly secreted VWF with ultralarge (UL) and high molecular weight multimers (HMWM) from endothelial cells and
Externí odkaz:
https://doaj.org/article/c7f8ff570ae54d518594b16cc59322bc
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Conjugation to polyethylene glycol (PEG) is commonly used to enhance drug delivery and efficacy by extending the half-life of the drug molecule. This has important implications for reducing treatment burden in diseases that require chronic prophylaxi
Externí odkaz:
https://doaj.org/article/cc5780b2cfd549f3b5595603973ef253
Autor:
Claude Négrier, Johannes Oldenburg, Gili Kenet, Shannon L. Meeks, Jean‐Claude Bordet, Jens Müller, Sandra Le Quellec, Peter L. Turecek, Nikola Tripkovic, Yesim Dargaud
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 4, Pp n/a-n/a (2022)
Abstract Background Neutralizing factor VIII (FVIII) antibodies are a major complication in hemophilia A. Antihemophilic factor VIII (recombinant), porcine sequence (rpFVIII; susoctocog alfa; Baxalta US Inc., a Takeda company) has low cross‐reactiv
Externí odkaz:
https://doaj.org/article/91ce143ec06b44f9b2022550f7cfd2c0
Autor:
Behnaz Pezeshkpoor, Nadja Sereda, Ann-Cristin Berkemeier, Isabell Matuschek, Nadine Schwarz, Peter L. Turecek, Silvia Horneff, Claudia Klein, Georg Goldmann, Natascha Marquardt, Thilo Albert, Jens Müller, Johannes Oldenburg
Publikováno v:
Journal of Thrombosis and Haemostasis. 21:1503-1514
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0493a8f8c0490281e24d2cf8b48bc49b
https://doi.org/10.1016/j.jtha.2023.03.011
https://doi.org/10.1016/j.jtha.2023.03.011
Autor:
Einas Elsheikh, Michelle Lavin, Lilian Antunes Heck, Niamh Larkin, Brendan Mullaney, Dearbhla Doherty, Megan Kennedy, Catriona Keenan, Thomas Guest, Brian O'Mahony, Judicael Fazavana, Padraic G. Fallon, Roger J.S. Preston, John Gormley, Kevin Ryan, Niamh M. O'Connell, Evelyn Singleton, Mary Byrne, Mark McGowan, Sheila Roche, Mairead Doyle, Maeve P. Crowley, Susan I. O'Shea, Birgit M. Reipert, Jill M. Johnsen, Steven W. Pipe, Jorge Di Paola, Peter L. Turecek, James S. O'Donnell
Publikováno v:
Journal of Thrombosis and Haemostasis. 21:1123-1134
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::466954f23f25d68ab01a21abab4d5434
https://doi.org/10.1016/j.jtha.2023.01.013
https://doi.org/10.1016/j.jtha.2023.01.013
Publikováno v:
Vox Sanguinis. 117:780-788
This review, written from the perspective of the plasma industry, discusses plasma procurement and plasma product safety in light of the COVID-19 pandemic. The COVID-19 pandemic impacted the whole world and, therefore, not unexpectedly, the pharmaceu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6916268bb946d2a2e7edeaa1f224ce29
https://doi.org/10.1111/vox.13267
https://doi.org/10.1111/vox.13267
Autor:
Megan, Kennedy, Sheila, Roche, Mark, McGowan, Evelyn, Singleton, Einas, Elsheikh, Mairead, O'Donovan, Kevin, Ryan, Niamh M, O'Connell, Brian, O'Mahony, Michelle, Lavin, James S, O'Donnell, Peter L, Turecek, John, Gormley
Publikováno v:
Haemophilia : the official journal of the World Federation of HemophiliaREFERENCES.
This study aimed to examine physical activity (PA), physical fitness and cardiometabolic risk amongst people with moderate and severe haemophilia (PwMSH).The following domains were examined: PA (accelerometry); functional aerobic capacity (6-Minute W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22867c5f232a5199719442a6d0c09b53
https://pubmed.ncbi.nlm.nih.gov/36195106
https://pubmed.ncbi.nlm.nih.gov/36195106
Autor:
Herbert Gritsch, Gerald Schrenk, Nina Weinhappl, Björn Mellgård, Bruce Ewenstein, Peter L Turecek
Publikováno v:
Journal of blood medicine. 13
Herbert Gritsch,1 Gerald Schrenk,1 Nina Weinhappl,1 Björn Mellgård,2 Bruce Ewenstein,2 Peter L Turecek3,4 1Pharmaceutical Sciences, Baxalta Innovations GmbH, a Takeda Company, Vienna, Austria; 2Rare Genetics and Hematology, Research & Developme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af6897bdd673fefa5cc70c9ff70595e6
https://pubmed.ncbi.nlm.nih.gov/36405429
https://pubmed.ncbi.nlm.nih.gov/36405429
Autor:
Reinhard Stidl, Michael Denne, Jimena Goldstine, Bill Kadish, Katherine I. Korakas, Peter L. Turecek
Publikováno v:
Pharmaceuticals, Vol 11, Iss 3, p 75 (2018)
Polyethylene glycol (PEG) is an inert, water soluble polymer, used for decades in pharmaceuticals. Although PEG is considered safe, concerns persist about the potential adverse effects of long-term exposure to PEG-containing therapies, specifically i
Externí odkaz:
https://doaj.org/article/da7eb9ec253340b6b55e420248da4f95
Autor:
Claude Négrier, Johannes Oldenburg, Gili Kenet, Shannon L. Meeks, Jean‐Claude Bordet, Jens Müller, Sandra Le Quellec, Peter L. Turecek, Nikola Tripkovic, Yesim Dargaud
Publikováno v:
Research and practice in thrombosis and haemostasis. 6(4)
Neutralizing factor VIII (FVIII) antibodies are a major complication in hemophilia A. Antihemophilic factor VIII (recombinant), porcine sequence (rpFVIII; susoctocog alfa; Baxalta US Inc., a Takeda company) has low cross-reactivity to anti-human FVII
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40881d54e03f59f903b155c018fa758e
https://pubmed.ncbi.nlm.nih.gov/35765670
https://pubmed.ncbi.nlm.nih.gov/35765670